tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

BDXBecton Dickinson

Health care · Medical Instruments · NYSE
Compare with peers → Embed
What it said it expected, against what it reported

2 targets with a reported result

Releases of the last 3 years
Above the range
0
above the last range given
Within the range
1
of 2 range targets
Below the range
1
below the last range given

The numbers BDX said it expected, in its earnings releases, next to what it then reported for the same period.

Target by target

Each target, with the sentence it came from

Release and 10-Q or 10-K
TargetWhat the company saidReportedResult
Diluted EPS (company-defined)
Fiscal 2026
Given $12.35 to $12.65 release 2026-02-09
Raised $12.52 to $12.72 release 2026-05-07
Raised $12.62 to $12.72 release 2026-08-06
– No standard number
The company's words
Fiscal 2026 New BD Guidance as of February 9, 2026 GAAP Revenue Growth Low single-digit plus Revenue Growth (FXN) Low single-digit … Adjusted Diluted EPS $12.35 to $12.65 release 2026-02-09
Updated New BD Guidance Prior New BD Guidance as of May 7, 2026 as of February 9, 2026 GAAP Revenue Growth Low single-digit plus Low single-digit plus Revenue G … Adjusted Diluted EPS $12.52 to $12.72 release 2026-05-07
Updated New BD Guidance Prior New BD Guidance as of August 6, 2026 as of May 7, 2026 GAAP Revenue Growth Low single-digit plus Low single-digit plus Revenue Gro … Adjusted Diluted EPS $12.62 to $12.72 release 2026-08-06
Diluted EPS (company-defined)
Fiscal 2025 (ended 2025-09-30)
Given $14.25 to $14.60 release 2024-11-07
Raised $14.30 to $14.60 release 2025-02-05
Lowered $14.06 to $14.34 release 2025-05-01
Raised $14.30 to $14.45 release 2025-08-07
– No standard number
The company's words
Company issues FY25 adjusted diluted EPS guidance of $14.25 to $14.60 1 , which reflects growth of about 10% at the midpoint release 2024-11-07
The company provided the following guidance with respect to fiscal 2025. … The company increased its Adjusted Diluted EPS guidance to a range of $14.30 to $14.60, which reflects growth of 10% at the midpoint. release 2025-02-05
Fiscal 2025 Guidance as Fiscal 2025 Guidance as of of May 1, 2025 February 5, 2025 … Adjusted Diluted EPS $14.06 to $14.34 release 2025-05-01
Assumptions and Outlook for Full Year Fiscal 2025 … The company raised its full-year adjusted EPS guidance to $14.30 to $14.45, reflecting an $0.18 increase to 9.4% growth at the midpoint. release 2025-08-07
Revenue
Fiscal 2025 (ended 2025-09-30)
Given $21.90B to $22.10B release 2024-11-07
Lowered $21.70B to $21.90B release 2025-02-05
Raised $21.80B to $21.90B release 2025-05-01
Kept $21.80B to $21.90B release 2025-08-07
$21.84B
10-K filed 2025-11-25
Within the range
The company's words
Fiscal 2025 Guidance as of November 7, 2024 … GAAP Revenues ~ $21.9 to $22.1 billion release 2024-11-07
Fiscal 2025 Guidance as Fiscal 2025 Guidance as of of February 5, 2025 November 7, 2024 … GAAP Revenues ~ $21.7 to $21.9 billion release 2025-02-05
The company now expects fiscal 2025 revenues to be between $21.8 billion and $21.9 billion compared to its previously issued guidance of $21.7 billion to $21.9 billion. release 2025-05-01
Fiscal 2025 Guidance as Fiscal 2025 Guidance as of of August 7, 2025 May 1, 2025 … GAAP Revenues ~ $21.8 to $21.9 billion release 2025-08-07
Diluted EPS (company-defined)
Fiscal 2024 (ended 2024-09-30)
Given $12.82 to $13.06 release 2024-02-01
Raised $13.05 to $13.15 release 2024-08-01
– No standard number
The company's words
The company now expects fiscal year 2024 adjusted diluted EPS to be $12.82 to $13.06, compared to $12.70 to $13.00 previously. release 2024-02-01
The company provided the following guidance with respect to fiscal 2024. … The company increased its adjusted diluted earnings per share guidance by 5 cents at the midpoint to a range of $13.05 to $13.15 driven by the strength of its margin performance and updated margin outlook for the full fiscal year. release 2024-08-01
Revenue
Fiscal 2024 (ended 2024-09-30)
Given $20.20B to $20.40B release 2024-02-01
$20.18B
10-K filed 2024-11-27
Below the range
The company's words
The company now expects fiscal year 2024 revenues to be in the range of approximately $20.2 billion to $20.4 billion compared to $20.1 billion to $20.3 billion previously. release 2024-02-01
Revenue (company-defined)
Fiscal 2024 (ended 2024-09-30)
Given $20.10B to $20.20B release 2024-08-01
– No standard number
The company's words
Fiscal 2024 Guidance as Fiscal 2024 Guidance as of of August 1, 2024 May 2, 2024 … Adjusted Revenues ~ $20.1 to $20.2 billion release 2024-08-01

Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (15 releases since 2023-11-09), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.

Next Archive →